Kohjin Bio CoTSE:177A -2.15%19 Net Margin % is 2.01% as of Mar. 2026, which is 87% below its 10-year median of 14.89. GuruFocus rates TSE:177A with a GF Score™ of 19/100. The stock has 3 warning signs investors should review. Among 944 Biotechnology companies, Kohjin Bio Co ranks better than 75.95% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Kohjin Bio Co's Net Income for the
six
months ended in Mar. 2026 was 円49 Mil. Kohjin Bio Co's Revenue for the
six
months ended in Mar. 2026 was 円2,435 Mil. Therefore, Kohjin Bio Co's net margin for the quarter that ended in Mar. 2026 was 2.01%.
The historical rank and industry rank for Kohjin Bio Co's Net Margin % or its related term are showing as below:
TSE:177A'
s Net Margin % Range Over the Past 10 Years
Min: 5.08 Med: 14.89 Max: 17.5
Current: 5.08
TSE:177A's Net Margin % is ranked better than 75.95% of 944
companies
in the Biotechnology industry
Industry Median: -88.815
vs TSE:177A: 5.08
Kohjin Bio Co (TSE:177A) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Kohjin Bio Co Net Margin % Related Terms
Kohjin Bio Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Kohjin Bio Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:177A vs VRTX, REGN, ALNY: Net Margin % Comparison
For the Biotechnology subindustry, Kohjin Bio Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kohjin Bio Co Net Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Kohjin Bio Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kohjin Bio Co (TSE:177A) has a Net Margin % of 2.01% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Kohjin Bio Co and its competitors. This is 87% below median its historical median of 14.89. Over the past decade, Kohjin Bio Co's Net Margin % has ranged from 5.08 to 17.50. According to the industry distribution chart, Kohjin Bio Co ranks #227 out of 944 companies in the Biotechnology industry, placing it in the top 24%.
Is Kohjin Bio Co's Net Margin % too high?
Kohjin Bio Co's current Net Margin % of 2.01% is 87% below median its 10-year median of 14.89. Over the past 10 years, this metric has ranged from a low of 5.08 to a high of 17.50. Based on the distribution chart, Kohjin Bio Co ranks #227 out of 944 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Kohjin Bio Co has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kohjin Bio Co ranks #227 out of 944 companies for Net Margin %. This places Kohjin Bio Co in the top 24% of its industry — outperforming the majority of peers. Historically, Kohjin Bio Co's own Net Margin % has ranged from 5.08 to 17.50 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Kohjin Bio Co and its competitors. Kohjin Bio Co's current Net Margin % is 2.01%, which is 87% below median its own 10-year median of 14.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current Net Margin % of 2.01%. The current Net Margin % is 2.01%, which is 87% below median its 10-year median of 14.89. Kohjin Bio Co's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current Net Margin % is 2.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
19GF Score
Get the complete analysis for TSE:177A
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:177A has been successfully added to your 